| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.093 | 39.305 | 51.068 | 57.446 | 53.681 | 58.426 | 82.692 | 79.137 | 86.354 | 90.989 |
| Total Income - EUR | 5.093 | 39.305 | 51.069 | 57.450 | 53.685 | 58.427 | 84.713 | 79.140 | 86.357 | 90.998 |
| Total Expenses - EUR | 4.786 | 25.928 | 29.344 | 32.694 | 37.106 | 33.915 | 34.524 | 31.958 | 47.788 | 51.930 |
| Gross Profit/Loss - EUR | 307 | 13.378 | 21.725 | 24.756 | 16.579 | 24.511 | 50.189 | 47.182 | 38.570 | 39.068 |
| Net Profit/Loss - EUR | 154 | 12.984 | 21.215 | 24.182 | 16.042 | 23.967 | 49.362 | 46.391 | 37.706 | 36.338 |
| Employees | 4 | 4 | 4 | 4 | 6 | 3 | 4 | 3 | 3 | 4 |
Check the financial reports for the company - Kamal Wali Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 301 | 1.565 | 1.595 | 709 | 66 | 4.277 | 4.315 | 3.850 | 3.493 | 3.411 |
| Current Assets | 4.467 | 13.696 | 29.296 | 40.250 | 22.019 | 21.347 | 38.812 | 45.194 | 51.688 | 43.694 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 195 | 195 | 195 | 194 |
| Receivables | 2.354 | 3.606 | 5.520 | 5.080 | 4.641 | 2.593 | 7.777 | 35.370 | 34.444 | 16.159 |
| Cash | 2.114 | 10.090 | 23.776 | 35.171 | 17.378 | 18.754 | 30.840 | 9.629 | 17.049 | 27.341 |
| Shareholders Funds | 199 | 13.181 | 29.839 | 32.843 | 16.084 | 24.058 | 40.939 | 46.480 | 37.795 | 36.426 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | 4.570 | 2.080 | 1.052 | 8.287 | 6.000 | 1.566 | 2.188 | 2.564 | 17.386 | 10.679 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Kamal Wali Med S.r.l.